Direct links to the publications generated by the project
Single-cell RNA-seq analysis and cell-cluster deconvolution of the human preovulatory follicular fluid cells provide insights into the pathophysiology of ovarian hyporesponse.|21 Oct, 2023|Front Endocrinol (Lausanne)
- |2 Jun, 2023|Hum Genomics
A chromosome-level reference genome for the common octopus, Octopus vulgaris (Cuvier, 1797) - Preprint|18 May, 2023|BioRxiv
Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors - Preprint|8 May, 2023|Research Square
- |28 Apr, 2023|Int. J. Mol. Sci.
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.|5 Apr, 2023|Genome Med.
Human genetic and immunological determinants of SARS-CoV-2 and Epstein-Barr virus diseases in childhood: Insightful contrasts|26 Mar, 2023|J Intern Med.
- |22 Feb, 2023|
- |10 Feb, 2023|Science
- |7 Nov, 2022|J Exp Med.
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative|3 Nov, 2022|PLoS Genetics
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.|3 Nov, 2022|PLoS Genet.
- |16 Sep, 2022|J Exp Med.
Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.|12 Sep, 2022|J Exp Med.
Equilibrated evolution of the mixed auto-/allopolyploid haplotype-resolved genome of the invasive hexaploid Prussian carp|14 Jul, 2022|Nat Commun.
- |7 Jun, 2022|J Exp Med.
- |20 Apr, 2022|J Exp Med.
- |23 Mar, 2022|J Exp Med.
- |28 Jan, 2022|Nature
- |10 Dec, 2021|Hum Genet.
A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15.|30 Nov, 2021|J Exp Med.
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona.|27 Sep, 2021|J Clin Immunol.
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.|19 Aug, 2021|Sci Immunol.
- |19 Aug, 2021|Sci Immunol.
- |7 Jun, 2021|J Exp Med.
Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.|13 Apr, 2021|J Clin Immunol.
Combining Nanopore and Illumina Sequencing Permits Detailed Analysis of Insertion Mutations and Structural Variations Produced by PEG-Mediated Transformation in Ostreococcus tauri.|17 Mar, 2021|Cells
Combining Nanopore and Illumina Sequencing Permits Detailed Analysis of Insertion Mutations and Structural Variations Produced by PEG-Mediated Transformation in Ostreococcus tauri|17 Mar, 2021|Cells
- |11 Nov, 2020|Nucleic Acids Research
Hybridization-based in situ sequencing (HybISS) for spatially resolved transcriptomics in human and mouse brain tissue|4 Nov, 2020|Nucleic Acids Research
- |23 Oct, 2020|SCIENCE
- |23 Oct, 2020|Science
- |7 Oct, 2020|Nature Communications
- |20 Sep, 2020|Science
- |6 Aug, 2020|Front Pediatr.
- |16 Jul, 2020|BMC Genomics
Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies|8 Feb, 2020|Cancers
- |1 Feb, 2020|EASI genomics newsletter Feb 2020
- |1 Jan, 2020|EASI genomics newsletter Jan 2020
- |13 Nov, 2019|Nucleic Acids Research